載入...
Combination therapy for advanced hepatocellular carcinoma: do we see the light at the end of the tunnel?
IMPORTANCE: Combination therapies of anti-PD-1 and anti-angiogenesis regimens are emerging rapidly and exhibit more promising anti-tumor efficacy for advanced hepatocellular carcinoma (HCC), and consistently it is the hotspot in clinical studies. OBJECTIVE: To elaborate several issues which are warr...
Na minha lista:
| 發表在: | Hepatobiliary Surg Nutr |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8050575/ https://ncbi.nlm.nih.gov/pubmed/33898559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn-2021-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|